Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Suryakumar Reddy

Vascular & Interventional Radiology Wichita, KS Medical Doctor

NPI 1508849787 CMS profile 491848

929 N Saint Francis St, Wichita, KS 67214

Open in the dashboard

General payments

$10,267

56 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Suryakumar Reddy of Wichita, KS is reported in the CMS Open Payments database as having received $10,267 across 56 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $508 4
2024 General $440 5
2023 General $3,320 12
2022 General $351 6
2019 General $5,648 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Suryakumar Reddy
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Suryakumar Reddy were reported at $508. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Suryakumar Reddy Vascular & Interventional Radiology median Middle half National median
2019 $5,648 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $0 $280 $99–$866 $132
2022 $351 $433 $137–$1,497 $149
2023 $3,320 $506 $152–$2,019 $160
2024 $440 $556 $175–$1,930 $164
2025 $508 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $3,569 15 payments
  2. Siemens Medical Solutions USA, Inc. $2,245 1 payment
  3. Inari Medical, Inc. $1,206 7 payments
  4. Stryker Corporation $1,203 8 payments
  5. Imperative Care, INc $1,001 11 payments
  6. Philips Electronics North America Corporation $319 3 payments
  7. Terumo Medical Corporation $178 2 payments
  8. MicroVention, Inc. $164 1 payment
  9. Medtronic, Inc. $96 1 payment
  10. Globus Medical, Inc. $85 1 payment
  11. Other $200 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $6,669 16 payments
  2. Food and Beverage $3,598 40 payments
Products named General payments · program years 2019–2025
  1. Penumbra System $4,847 13 payments
  2. ARTIS icono biplane $2,245 1 payment
  3. FlowTriever $779 4 payments
  4. ClotTriever $779 4 payments
  5. ZOOM 88-T LARGE DISTAL PLATFORM $595 7 payments
  6. FLOWTRIEVER CATHETER, S $427 3 payments
  7. CT THROMBECTOMY SYSTEM KIT $427 3 payments
  8. TARGET $405 3 payments
  9. TREVO $321 2 payments
  10. SYMPHONY CATHETER $286 3 payments
  11. Other $1,741 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Diagnostic Radiology: 24

Drug cost

$59

Median for Diagnostic Radiology: $190

Branded share of claims

100%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 12 $59

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 233 billing codes

Paid by Medicare

$143,147

Medicare's payments for the services billed

Medicare patients

1,780

Average age 74

Services billed

2,944

944 women, 836 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Ischemic heart disease 47%
Diabetes 39%
Atrial fibrillation 38%
Depression 38%
Heart failure 36%
Chronic kidney disease 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record